| 注册
首页|期刊导航|天津科技大学学报|肿瘤免疫细胞治疗研究进展

肿瘤免疫细胞治疗研究进展

刁爱坡 赵青

天津科技大学学报2018,Vol.33Issue(1):1-8,8.
天津科技大学学报2018,Vol.33Issue(1):1-8,8.DOI:10.13364/j.issn.1672-6510.20170183

肿瘤免疫细胞治疗研究进展

Research Progress in Immune Cell-mediated Cancer Therapy

刁爱坡 1赵青1

作者信息

  • 1. 天津科技大学生物工程学院,天津 300457
  • 折叠

摘要

Abstract

Immune cell-mediated cancer therapy is an innovative treatment for cancers,which belongs to tumor immuno-therapy and aims to treat tumor through regulating the immune response.Immune cell-mediated cancer therapy has achieved remarkable clinical effects on both hematological malignancies and solid tumors with the development of tumor immu-nological theory and technology.It might make great advancements in cancer treatment after surgery,chemotherapy, radiotherapy and targeted therapy.Here we summarized the research progress in immune cell-mediated cancer therapy using chimeric antigen receptor(CAR)T cells,natural killer(NK)cells or macrophage.

关键词

肿瘤免疫细胞治疗/嵌合抗原受体T细胞/自然杀伤细胞/巨噬细胞

Key words

immune cell-mediated cancer therapy/chimeric antigen receptor T cell/natural killer cells/macrophage

分类

医药卫生

引用本文复制引用

刁爱坡,赵青..肿瘤免疫细胞治疗研究进展[J].天津科技大学学报,2018,33(1):1-8,8.

基金项目

国家自然科学基金资助项目(31471335) (31471335)

天津科技大学学报

OACSTPCD

1672-6510

访问量0
|
下载量0
段落导航相关论文